AUSTIN, Texas, Nov. 3, 2020 /PRNewswire-PRWeb/ -- hyperCORE International, an integrated research organization, announced the addition of MOORE Clinical Research as a new partner to accommodate the organization's rapid business growth.
The partnership with MOORE Clinical Research (MCR), based in Tampa Bay, Fla., represents a 20% growth of the hyperCORE International organization this year. This expansion is a continuation of a strategic 2020 growth plan to facilitate increased services for hyperCORE International's CRO and sponsor partnerships.
"We are excited to have MOORE Clinical as part of the hyperCORE International network of elite sites and their expertise and knowledge in the Dermatology space will further develop and enhance our entire network capabilities," said Karri Venn, CEO of hyperCORE. "Diversification is key to ensure we deliver for our preferred partners, so welcoming new members to our team with excellence in a therapeutic area is one of our strategic priorities."
"MOORE Clinical Research is very excited to be joining hyperCORE International. We are confident that we'll make a significant contribution to the organization and we're very grateful for the opportunity to collaborate with other industry leaders in clinical research," said Jeffrey Smyth, CEO of MCR. "Thank you to the hyperCORE team for the confidence they have expressed in our company. We look forward to a long and productive relationship with this distinguished collection of research professionals."
If you are interested in becoming a member of hyperCORE's expanding and exceptional organization, please contact Michael Casey Executive Director of hyperCORE via email at [email protected] to begin the process.
About hyperCORE International:
Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. It is an industry leader, providing Phase I-IV clinical trial services with almost 100 active research sites across the globe. Its member companies have completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 60,000 patients. Each member operates as an independent company but integrates common functions to streamline business and clinical operations by offering a single contract and point of contact, centralized budget and shared platforms.
hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation.
Learn more at http://www.hyperCOREinternational.com
About MOORE Clinical Research
Founded in 2006, MOORE Clinical Research, Inc. (MCR) is a privately owned and operated, three-site research center located in the Tampa Bay metro area, with a proud reputation and consistent record of quality, integrity and reliability. MCR specializes in conducting Phase II-IV clinical trials in multi-therapeutic areas. The team comes with over 150 years of research experience collectively and are highly trained and credentialed Board-Certified MDs, Registered Nurses, Nurse Practitioners, Research Coordinators & Research Assistants with experience in Dermatology, Immunology, Internal Medicine, Neurology and Mental Health research. The experienced team at MCR maintains the high standards expected by the industry, to consistently follow established standards and regulations and to always deliver prompt, accurate results.
SOURCE hyperCORE International
Share this article